Didrik F. Vestrheim
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Serotype distribution of remaining invasive pneumococcal disease after extensive use of ten-valent and 13-valent pneumococcal conjugate vaccines (the PSERENADE project): a global surveillance analysis.
Journal: The Lancet. Infectious diseases
Published: May 31, 2024
Social contact patterns during the early COVID-19 pandemic in Norway: insights from a panel study, April to September 2020.
Journal: BMC public health
Published: December 15, 2023
Global spatial dynamics and vaccine-induced fitness changes of Bordetella pertussis.
Journal: Science translational medicine
Published: April 27, 2022
Phylogenetic Structure and Comparative Genomics of Multi-National Invasive Haemophilus influenzae Serotype a Isolates.
Journal: Frontiers in microbiology
Published: January 17, 2022
Evolution of Bordetella pertussis in the acellular vaccine era in Norway, 1996 to 2019.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: December 22, 2021
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe.
Journal: Emerging infectious diseases
Published: December 21, 2021
Health communication in and out of public health emergencies: to persuade or to inform?
Journal: Health research policy and systems
Published: December 07, 2021
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study.
Journal: Vaccine
Published: November 03, 2021
Sociodemographic determinants of catch-up HPV vaccination completion between 2016-2019 in Norway.
Journal: Human vaccines & immunotherapeutics
Published: October 29, 2021
Easy access to vaccination was important for adherence during the 2016-2019 HPV catch-up vaccination in Norway.
Journal: Human vaccines & immunotherapeutics
Published: October 06, 2021
The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children.
Journal: Microorganisms
Published: July 01, 2021
Last Updated: 09/26/2026